Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Influenza, Human × Fluzone High-Dose × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms, Plasma Cell 1 Neoplasms 1 Myelodysplastic Syndromes 1 Leukemia, Myeloid, Acute 1 Influenza, Human 1

Interventions

Influenza Vaccines 14 trivalent baculovirus-expressed influenza-virus hemagglutinin vaccine 2 Vaccines 2 Cyclophosphamide 2 ziprasidone 1 thymoglobulin 1 peginterferon alfa-2a 1 fludarabine 1 baloxavir 1 Zolpidem 1 Warfarin 1 Vecuronium Bromide 1 Vancomycin 1 Tranexamic Acid 1 Tobramycin 1 Spironolactone 1 Sevelamer 1 Rocuronium 1 Rituximab 1 Piperacillin, Tazobactam Drug Combination 1 Pentobarbital 1 Oxycodone 1 Oseltamivir 1 Nivolumab 1 Nifedipine 1 Nafcillin 1 Molindone 1 Methylprednisolone 1 Melphalan 1 Lurasidone Hydrochloride 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01666782 2016-06-24

IMMUNE

Rochester General Hospital

Phase 2 Completed

105 enrolled 10 charts

Influenza, Human, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡